4th Quarter - Report

AMERICAN SOCIETY OF CLINICAL ONCOLOGY for AMERICAN SOCIETY OF CLINICAL ONCOLOGY

Firm
Client
Income
—
Expenses
$21,825
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1844, Comprehensive Cancer Care Improvement Act, seeking cosponsors

LobbyistCovered position, as disclosed
ROBERT BLACKWELL —
SHELAGH FOSTER —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1844 (111th)

Medicare/Medicaid MMM

H.R. 1392 and S. 1221- an act to ensure more appropriate payment for drugs under Medicaer Part B; seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors H.R. 4994, Medicare and Medicaid Extenders Act of 2010

LobbyistCovered position, as disclosed
ROBERT BLACKWELL —
SHELAGH FOSTER —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1221 (111th), H.R. 4994 (111th), H.R. 1392 (111th), H.R. 3095 (111th)

Budget/Appropriations BUD

General Appropriations issues related to cancer research, the National Institutes of Health, the National Cancer Institute, and the Food and Drug Administration H J Res 101, 2nd Continuing Resolution; H J Res 105, 3rd Continuing Resolution; HR 3028 FY 2011 Continuing Resolution through March 4, 2011

LobbyistCovered position, as disclosed
ROBERT BLACKWELL —
SHELAGH FOSTER —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 3028 (111th), H.J.Res. 105 (111th), H.J.Res. 101 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.